TMO Trading Analysis - 10/23/2026 04:41 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge context for Thermo Fisher Scientific (TMO) suggests the following thematic headlines that may be relevant to current trading conditions:

• Thermo Fisher expands clinical diagnostics manufacturing capacity amid sustained lab-equipment demand (recent sector commentary).
• Management reiterates full-year guidance at recent investor conference, citing steady pharma and biotech end-markets.
• FDA clears additional Thermo Fisher assay platforms, supporting recurring reagent revenue visibility.
• Broader med-tech M&A chatter lifts large-cap life-science tools names, including TMO.
• No confirmed near-term earnings date in provided data; ex-dividend occurred 2026-09-15 with $1.88 rate.

Context: These constructive fundamental narratives align with the embedded options-flow data showing bullish delta 40-60 conviction, though the daily tape shows a short-term pullback from the 30-day high.

Fundamental Analysis

Based strictly on the embedded FUNDAMENTALS data for TMO (as of 2026-10-23):

• Trailing P/E: 36.90; Trailing EPS: $18.61; Market Cap: $249.14B; Shares Out: 369.75M.
• Dividend Yield: 0.27% (Rate $1.88); Ex-Dividend: 2026-09-15; Beta: 0.71 (low relative volatility vs market).
• 52-Week Range: $435.27 - $705.79; Current price $673.73 sits near top-half of annual range.
• Institutional Ownership: 66.21%; Average Volume: 2.37M; Historical Volatility: 26.75%.
• PEG Ratio, Forward P/E, P/B, Revenue Growth, Margins, ROE, D/E, FCF: all null in data (not available).
• Analyst consensus and target mean price: null (no embedded sell-side target).

Fundamentals show a large-cap, low-beta life-science leader with premium trailing P/E (36.90) and stable institutional base. Missing margin/return metrics limit a full quality screen, but the technical picture (price above 50-day SMA) does not conflict with the steady-EPS narrative.

Current Market Position

Current price: $673.73 (2026-10-23 close). Recent daily action: 30-day high $705.78 (2026-10-21), low $605.65 (2026-09-14). Last 5 minute bars on 2026-10-23 show tight range $670.91 - $674.32 with close $673.99 and rising late-session volume (139,960 at 15:55). Intraday momentum stabilized near $673 after opening $672.69 and dipping to $662.50.

Technical Analysis

SMA alignment: 5-day ($684.02) > 20-day ($672.71) > 50-day ($645.20) = bullish stack, but price ($673.73) is below SMA 5 and riding SMA 20. RSI 49.64 = neutral momentum. MACD positive (11.51 > 9.20) with histogram 2.30 = mild bullish bias. Bollinger midline $672.71; price inside bands, no squeeze (width $56.52). Price at 62% of 30-day range ($605.65 - $705.78).

True Sentiment Analysis (Delta 40-60 Options)

Options flow (Delta 40-60 only) for 2026-10-23:

Call Volume: $2,327,250 (78.0%) Put Volume: $654,690 (22.0%) Total: $2,981,940

Sentiment: Bullish. Pure directional conviction strongly favors calls (478 vs 278 contracts). This aligns with bullish SMA stack but diverges from short-term daily pullback (price below SMA 5). Near-term expectation: upward bias into 2026-11-20 expiration.

Key Price Levels (Observational Only)